Okla. Stat. tit. 56, § 56-4003
This is the official text of Okla. Stat. tit. 56, § 56-4003, part of Oklahoma’s Stat. tit. 56, — part of the compiled statutory law of Oklahoma, published by the state as "Stat. tit. 56,." Browse the sections below, each linked to its official government source.
Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.
Biomarker testing coverage
Official statutory text
A. As used in this section:
1. "Biomarker", "biomarker testing", "consensus statement", and
"nationally recognized clinical practice guidelines" shall have the
same meaning as provided by Section 1 of this act; and
2. "Contracted entity" shall have the same meaning as provided
by Section 4002.2 of Title 56 of the Oklahoma Statutes.
B. The state Medicaid program shall cover biomarker testing in
accordance with the requirements provided by this section.
C. Biomarker testing shall be covered for the purposes of
diagnosis, treatment, appropriate management, or ongoing monitoring
of a member’s disease or condition when the test is supported by
medical and scientific evidence, including, but not limited to:
Oklahoma Statutes - Title 56. Poor Persons Page 322
1. Labeled indications for a United States Food and Drug
Administration (FDA)-approved or -cleared test;
2. Indicated tests for an FDA-approved drug;
3. Warnings and precautions on FDA-approved drug labels;
4. Centers for Medicare and Medicaid Services (CMS) national
coverage determinations or Medicare Administrative Contractor (MAC)
local coverage determinations; or
5. Nationally recognized clinical practice guidelines and
consensus statements.
D. Contracted entities under the state Medicaid program shall
provide biomarker testing at the same scope, duration, and frequency
as the Medicaid program otherwise provides to members.
E. If prior authorization is required for biomarker testing,
the contracted entity shall approve or deny a prior authorization
request and notify the member, the member’s provider, and any entity
requesting authorization of the service within seventy-two (72)
hours for non-urgent requests or within twenty-four (24) hours for
urgent requests.
F. The member and the member’s provider shall have access to
clear, readily accessible, and convenient processes to request an
exception to a coverage policy for biomarker testing of the state
Medicaid program. The process shall be made readily accessible to
all participating providers and members online.
1. "Biomarker", "biomarker testing", "consensus statement", and
"nationally recognized clinical practice guidelines" shall have the
same meaning as provided by Section 1 of this act; and
2. "Contracted entity" shall have the same meaning as provided
by Section 4002.2 of Title 56 of the Oklahoma Statutes.
B. The state Medicaid program shall cover biomarker testing in
accordance with the requirements provided by this section.
C. Biomarker testing shall be covered for the purposes of
diagnosis, treatment, appropriate management, or ongoing monitoring
of a member’s disease or condition when the test is supported by
medical and scientific evidence, including, but not limited to:
Oklahoma Statutes - Title 56. Poor Persons Page 322
1. Labeled indications for a United States Food and Drug
Administration (FDA)-approved or -cleared test;
2. Indicated tests for an FDA-approved drug;
3. Warnings and precautions on FDA-approved drug labels;
4. Centers for Medicare and Medicaid Services (CMS) national
coverage determinations or Medicare Administrative Contractor (MAC)
local coverage determinations; or
5. Nationally recognized clinical practice guidelines and
consensus statements.
D. Contracted entities under the state Medicaid program shall
provide biomarker testing at the same scope, duration, and frequency
as the Medicaid program otherwise provides to members.
E. If prior authorization is required for biomarker testing,
the contracted entity shall approve or deny a prior authorization
request and notify the member, the member’s provider, and any entity
requesting authorization of the service within seventy-two (72)
hours for non-urgent requests or within twenty-four (24) hours for
urgent requests.
F. The member and the member’s provider shall have access to
clear, readily accessible, and convenient processes to request an
exception to a coverage policy for biomarker testing of the state
Medicaid program. The process shall be made readily accessible to
all participating providers and members online.
Status: in_force · Read it on the official government site
Need a lawyer in Oklahoma?
Find a Oklahoma lawyer
About this page: Statute text is reproduced from official government publishers via the
Open US Law dataset
(Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine
(Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.